IVIG: Clinical Trials

34 trials of IVIG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 5 terminated, 4 withdrawn, 3 active not recruiting. 34 Phase 2, 8 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 234Completed 16, Terminated 5, Withdrawn 4, Active not recruiting 3, Unknown 3, Not yet recruiting 2, Recruiting 1
Phase 38Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 2, Withdrawn 1

Follow IVIG: new trials by email Literature Review of IVIG trials Research Report on IVIG

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Therapeutic Plasma Exchange, Rituximab, Intravenous immunoglobulin - Idiopathic Pulmonary Fibrosis
Phase 2Not yet recruitingUniversity of Alabama at Birmingham522026-12-012026-10-20
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
IVIG, Aspirin, Firsekibart - Kawasaki Disease
Phase 2 / Phase 3Not yet recruitingChildren's Hospital of Fudan University902026-11-012026-10-22
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Immune Globulin Intravenous - Myeloma, Non Hodgkin's Lymphoma
Phase 2 / Phase 3RecruitingMonash University9002025-04-282025-10-07
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
Poly ICLC, IVIG - Stage IV NSCLC
Phase 1 / Phase 2WithdrawnVA Office of Research and Development2024-06-042024-09-19
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
Prednisone, IVIg - Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1002023-10-192024-08-29
Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)
Gamunex-C, Albumin - Immune-Mediated Necrotizing Myopathy
Phase 2WithdrawnUniversity of Washington2022-05-012022-10-24
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
plasmapheresis device, Intravenous immunoglobulin - Guillain-Barre Syndrome
Phase 2 / Phase 3CompletedAssiut University812021-09-012023-04-06
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring), Prednisolone Tablets, Human Albumin Solution - Habitual Abortion, Recurrent Pregnancy Loss
Phase 2CompletedAalborg University Hospital802021-01-282025-11-24
Open-label Trial of IVIG in Children With PANS
Privigen Injectable Product (Intravenous Immunoglobulin) - PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
Phase 2CompletedGöteborg University172021-01-122026-03-06
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Infliximab, Intravenous Immunoglobulin Therapy, Prednisone - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 2TerminatedECOG-ACRIN Cancer Research Group12021-01-072026-09-29
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Rituximab, IVIg - Pemphigus
Phase 2Active not recruitingThe University of Hong Kong202020-06-202025-07-08
Autologous Transplant To End NMO Spectrum Disorder
Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease
Phase 2 / Phase 3WithdrawnNorthwestern University2019-11-012019-11-20
IVIG (Gamunex-C) Treatment Study for POTS Subjects
IVIG, Albumin - Postural Tachycardia Syndrome
Phase 1 / Phase 2CompletedUniversity of Texas Southwestern Medical Center302018-10-292024-09-19
Cardiac Safe Transplants for Systemic Sclerosis
Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma
Phase 2 / Phase 3TerminatedNorthwestern University92018-05-172020-08-12
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Intravenous immunoglobulin, Placebo, Rituximab - Psychosis, Autoimmune Encephalitis
Phase 2Active not recruitingUniversity of Cambridge702017-11-012026-05-22
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Prednisone, Vinblastine, mercaptopurine - Langerhans Cell Histiocytosis
Phase 2 / Phase 3Active not recruitingNorth American Consortium for Histiocytosis14002016-11-022026-11-10
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
IVIg - Recurrent Pregnancy Loss
Phase 2CompletedTabriz University of Medical Sciences502016-09-202018-09-17
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure
IVIg - Recurrent Implantation Failure
Phase 2CompletedTabriz University of Medical Sciences502016-07-202018-09-17
Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
Eculizumab, Immunoglobulin, Plasmapheresis - Antibody-mediated Rejection, Humoral Rejection
Phase 2TerminatedBrigham and Women's Hospital112013-11-012017-09-21
Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS
Sertraline+Antibiotic (penicillin/azithromycin), Sertraline+placebo, IVIG - Pandas
Phase 2WithdrawnCNS Onlus2013-06-012023-02-21

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Autoimmune Diseases of the Nervous System (2)  ·  Kidney Failure, Chronic (2)  ·  Neoplasms (2)  ·  Pemphigus (2)  ·  Purpura, Thrombocytopenic, Idiopathic (2)  ·  Abortion, Habitual (1)  ·  Abortion, Spontaneous (1)  ·  Agammaglobulinemia (1)  ·  Alzheimer Disease (1)  ·  Autoimmune Diseases (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Disease Progression (1)  ·  Drug Resistant Epilepsy (1)  ·  Epilepsies, Partial (1)

Sponsors

Grifols Therapeutics LLC (4)  ·  Northwestern University (2)  ·  Tabriz University of Medical Sciences (2)  ·  Aalborg University Hospital (1)  ·  Assiut University (1)  ·  Brigham and Women's Hospital (1)  ·  CNS Onlus (1)  ·  Cedars-Sinai Medical Center (1)  ·  Children's Hospital of Fudan University (1)  ·  Columbia University (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Emory University (1)  ·  GammaCan (1)  ·  Göteborg University (1)  ·  Haukeland University Hospital (1)

Countries

United States (19)  ·  Canada (2)  ·  China (2)  ·  Germany (2)  ·  Iran (2)  ·  Israel (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Greece (1)  ·  Hong Kong (1)

Top investigators

Mehdi Yousefi, Immunologist (2)  ·  Mohammad Nouri, Ph.D (2)  ·  Richard Burt, MD (2)  ·  Alasdair Coles, PhD FRCP (1)  ·  Anil K Chandraker, MD (1)  ·  Avroy A. Fanaroff, MD (1)  ·  Carlos Rodriguez-Galindo, MD (1)  ·  Charles M. Epstein, M.D. (1)  ·  Charles R. Bauer, MD (1)  ·  Christopher Gillberg, Professor (1)  ·  Curie Ahn, MD (1)  ·  Dan Aderka, M.D. (1)  ·  Elisabeth Farbu, MD, PhD (1)  ·  Elizabeth C. Wright, PhD (1)  ·  Fang Liu, MD (1)

Results publications

PMID 12765346, PMID 17166218, PMID 19710204, PMID 19819893, PMID 21095154, PMID 22889462, PMID 24628478, PMID 18645164, PMID 23375965, PMID 25090414, PMID 26083430, PMID 26844479, PMID 31174586, PMID 32612255, PMID 33568350, PMID 35933358, PMID 36137638, PMID 38509495, PMID 41263919, PMID 8133853, PMID 9686724

NIH funding

U01HD019897 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD021415 (1), UG1CA189828 (1)